Dr. Frank I. Lin National Cancer Institute, USA

Dr. Lin attended Stanford University where he received his B.S. in Biological Sciences in 1998 before going on to earn his MD at the Medical College of Wisconsin. He did his clinical training in Nuclear Medicine at the University of California – Davis in 2009 and completed it with a... read moreMedical Oncology fellowship at the U.S. National Institutes of Health in 2017. Dr. Lin has received various honors for his work including being appointed a Lasker Clinical Research Scholar by the National Cancer Institute in the U.S., where he has been since 2010 and currently leads the targeted radioligand therapy program there. Being Board-Certified in both Nuclear Medicine and Medical Oncology, Dr. Lin’s clinical practice and translational research laboratory focus on the use of targeted radioligand therapy to treat various cancers.